Dusseldorf - Delayed Quote EUR

Bavarian Nordic A/S (BV3.DU)

Compare
27.54 +0.54 (+2.00%)
As of 12:30:50 PM GMT+1. Market Open.
Currency in DKK All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
6,069,590.00
7,062,340.00
3,150,793.00
1,897,875.00
1,852,383.00
Cost of Revenue
2,890,347.00
2,459,294.00
1,449,531.00
1,327,560.00
1,195,094.00
Gross Profit
3,179,243.00
4,603,046.00
1,701,262.00
570,315.00
657,289.00
Operating Expense
2,036,040.00
3,100,507.00
1,772,047.00
883,862.00
277,701.00
Operating Income
1,143,203.00
1,502,539.00
-70,785.00
-313,547.00
379,588.00
Net Non Operating Interest Income Expense
-36,008.00
-63,015.00
-65,273.00
-118,136.00
-109,090.00
Pretax Income
1,122,624.00
1,482,943.00
-331,611.00
-454,430.00
281,976.00
Tax Provision
4,065.00
7,754.00
15,771.00
10,345.00
4,455.00
Net Income Common Stockholders
1,118,559.00
1,475,189.00
-347,382.00
-464,775.00
277,521.00
Diluted NI Available to Com Stockholders
1,118,559.00
1,475,189.00
-347,382.00
-464,775.00
277,521.00
Basic EPS
14.50
19.20
-4.90
-7.40
5.10
Diluted EPS
14.50
19.20
-4.90
-7.40
5.10
Basic Average Shares
77,500.93
76,710.56
70,418.39
63,104.00
54,046.00
Diluted Average Shares
77,500.93
76,710.56
70,418.39
63,104.00
54,046.00
Total Expenses
4,926,387.00
5,559,801.00
3,221,578.00
2,211,422.00
1,472,795.00
Net Income from Continuing & Discontinued Operation
1,118,559.00
1,475,189.00
-347,382.00
-464,775.00
277,521.00
Normalized Income
1,102,621.92
1,433,490.54
-185,081.94
-434,311.32
268,316.66
Interest Income
50,365.00
40,214.00
26.00
1,739.00
193.00
Interest Expense
89,898.00
105,519.00
119,689.00
152,060.00
177,002.00
Net Interest Income
-36,008.00
-63,015.00
-65,273.00
-118,136.00
-109,090.00
EBIT
1,212,522.00
1,588,462.00
-211,922.00
-302,370.00
458,978.00
EBITDA
1,266,002.00
2,142,283.00
187,325.00
85,940.00
819,125.00
Reconciled Cost of Revenue
2,890,347.00
2,459,294.00
1,449,531.00
1,327,560.00
1,195,094.00
Reconciled Depreciation
53,480.00
553,821.00
399,247.00
388,310.00
360,147.00
Net Income from Continuing Operation Net Minority Interest
1,118,559.00
1,475,189.00
-347,382.00
-464,775.00
277,521.00
Total Unusual Items Excluding Goodwill
15,995.00
41,908.00
-208,077.00
-39,056.00
9,354.00
Total Unusual Items
15,995.00
41,908.00
-208,077.00
-39,056.00
9,354.00
Normalized EBITDA
1,250,007.00
2,100,375.00
395,402.00
124,996.00
809,771.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
57.92
209.54
-45,776.94
-8,592.32
149.66
12/31/2020 - 6/16/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

7IZ.MU Ziccum AB
0.0298
-29.72%
 
5KW.F SkinBioTherapeutics plc
0.1660
-2.35%
 
IKAP.MU Aurinia Pharmaceuticals Inc
8.14
0.00%
 
HQ1.MU Oruka Therapeutics Inc. R
18.60
0.00%
 
XRP2.F Silence Therapeutics plc
5.95
+0.85%
 
ORN.F Oryzon Genomics S.A.
1.5020
+2.18%
 
BLE.BE bluebird bio Inc
0.3708
-3.01%
 
41X.F Ardelyx, Inc.
5.12
+0.16%
 
ALGEN.PA genOway Société anonyme
3.9000
+1.04%
 
PH4.F CStone Pharmaceuticals
0.2640
-1.49%